The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183).
 
Maha H. A. Hussain
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca; Clinical Care Options; Great Debates and Updates; Medscape; Merck; Precisca; Targeted Oncology; UroToday
Consulting or Advisory Role - AstraZeneca; Bayer; Bayer; Convergent Therapeutics; GlaxoSmithKline; GlaxoSmithKline; Janssen; Merck; Novartis; Pfizer; Tempus
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech (Inst); PCCTC (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - TITLE: Dual Inhibition of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases. Applicant/Proprietor Exelexis, Inc. Application No/Patent No. 11764665.4- 1464 Application No/Pat; TITLE: METHOD OF TREATING CANCER Docket No: Serial Number: 224990/10-016P2/311733 61/481/671 Application Filed on: 5/2/2011; TITLE: SYSTEMS AND METHODS FOR TISSUE IMAGING, 3676 Our File: Serial Number: UM-14437/US-1/PRO 60/923,385 UM-14437/US-2/ORD 12/101,753
 
Masha Kocherginsky
Patents, Royalties, Other Intellectual Property - Royalties - co-inventor on Patent 9149485, "Methods and compositions related to glucocorticoid receptor antagonists and breast cancer".
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; Janssen Oncology; Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Zin Myint
Consulting or Advisory Role - EMD Serono
 
Di Maria Jiang
Honoraria - Amgen; Bayer; EMD Serono; Ipsen; Janssen Oncology
Consulting or Advisory Role - Bayer; Pfizer/EMD Serono
 
Elizabeth Marie Wulff-Burchfield
Stock and Other Ownership Interests - Immunomedics (I); Nektar (I)
Consulting or Advisory Role - Aptitude Health; Astellas Scientific and Medical Affairs Inc; AVEO; Bristol-Myers Squibb; Exelixis; Janssen Oncology; Targeted Oncology
Research Funding - Acerta Pharma/AstraZeneca (Inst); Pfizer
Patents, Royalties, Other Intellectual Property - Methods of use patent application has been submitted for the pharmaceutical product Osanetant, owned by Acer Therapeutics.
 
Elad Sharon
No Relationships to Disclose
 
Richard Piekarz
No Relationships to Disclose
 
Joshua J Meeks
Honoraria - AstraZeneca; Bristol-Myers Squibb/Medarex; Foundation Medicine; incyte; Janssen; Merck; Nucleix; Urogen pharma
Consulting or Advisory Role - AstraZeneca; Ferring; Merck
Research Funding - Epizyme; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck Sharp & Dohme
 
David James VanderWeele
Honoraria - Astellas Pharma
Consulting or Advisory Role - Bayer; Clovis Oncology; Exelixis; Janssen
Research Funding - AstraZeneca (Inst); Department of Defense-Prostate Cancer Research Program; Fortis (Inst); Prostate Cancer Foundation